Inventory, net

9 Months Ended

Sep. 30, 2024

Inventory, net

Inventory, net

7. Inventory, net

Inventory, net consists of the following:

	September 30, 2024		December 31, 2023
Raw materials	$	2,124	$	2,639
Work-in-process		16		708
		2,140		3,347
Less Inventory Reserve for Obsolescence		(1,515)		(526)
Total	$	625	$	2,821

As of September 30, 2024 and December 31, 2023, inventory balances include inventory costs subsequent to regulatory approval of KORSUVA injection on August 23, 2021. During the three and nine months ended September 30, 2024, the Company wrote down $1,020 and $2,509, respectively, of commercial supply inventory due to obsolescence.